IRCT20220713055465N1
Probiotic supplementation in multiple sclerosis
The effects of probiotics in functional abilities of multiple sclerosis patients: a randomized double-blind placebo-control trial
Tabriz University of Medical Sciences·Phase 2·Iranian Registry Of Clinical Trial·biologicalRecruiting
Study focus
- Disease/Condition
- Multiple sclerosis
- Study type
- Interventional
- Intervention type
- biological
Sponsor & location
- Primary sponsor
- Tabriz University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 2
- Start date
- Aug 23, 2022
- End date
- N/A
ICD-10 classifications
Multiple sclerosisProgressive systemic sclerosisSystemic sclerosisSystemic sclerosis, unspecifiedDiffuse sclerosis
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20220713055465N1
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20220713055465N1 through Pure Global AI's free database. This Phase 2 trial is sponsored by Tabriz University of Medical Sciences and is currently Recruiting. The study focuses on Multiple sclerosis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.